Omura Kazonobu, Hitosugi Masahito, Kaketani Kazutoshi, Zhu Xia, Maeda Hiroaki, Tokudome Shogo
Department of Legal Medicine, Dokkyo University School of Medicine, Tochigi, Japan.
Biofactors. 2004;22(1-4):185-7. doi: 10.1002/biof.5520220138.
NKCP is the completely refined protein layer from cultured Bacillus subtilis (natto) and is supplied in tablet form. It lacks the distinctive fermented odor and bacteria associated with fresh natto. Almost all vitamin K is removed during the manufacturing process. The main component of NKCP is the active fragment of Bacillopeptidase F, which is a serine protease secreted by Bacillus subtilis. In in vivo studies, NKCP shows fibrinolytic and amidolytic activity on plasmin specific synthetic substrate. Daily oral administration of NKCP in 28 volunteers for two weeks and then in 23 volunteers for several months, was examined. The fibrinolytic effect was demonstrated by a shortened euglobulin lysis time in both trials. Furthermore, we observed an improvement in shoulder stiffness. These results suggest that the oral administration of NKCP can be expected to have a fibrinolytic effect and cause positive changes in local blood flow. Further investigations may demonstrate NKCP to be useful in the prevention of thrombosis.
NKCP是由培养的枯草芽孢杆菌(纳豆)制成的完全精制蛋白层,呈片剂形式供应。它没有新鲜纳豆特有的发酵气味和细菌。在制造过程中几乎所有的维生素K都被去除了。NKCP的主要成分是芽孢杆菌肽酶F的活性片段,芽孢杆菌肽酶F是枯草芽孢杆菌分泌的一种丝氨酸蛋白酶。在体内研究中,NKCP在纤溶酶特异性合成底物上显示出纤维蛋白溶解和酰胺分解活性。对28名志愿者进行了为期两周的每日口服NKCP试验,然后对23名志愿者进行了为期数月的试验。在两项试验中,优球蛋白溶解时间缩短证明了其纤维蛋白溶解作用。此外,我们观察到肩部僵硬有所改善。这些结果表明,口服NKCP有望产生纤维蛋白溶解作用,并引起局部血流的积极变化。进一步的研究可能表明NKCP在预防血栓形成方面是有用的。